Comera Life Sciences Holdings- Warrants (19/05/2027) Total Revenue

The latest total revenue for CMRAW is $1M as of September 2023. That compares with $550K in the prior-year period — up 81.8% year over year. That is below the sector sector average of $1.3B. Investors often review this figure alongside Comera Life Sciences Holdings- Warrants (19/05/2027)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CMRAW's total revenue moved from $550K to $1M — a 81.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Comera Life Sciences Holdings- Warrants (19/05/2027)'s operating scale or balance-sheet position.

Against its sector companies, CMRAW currently prints $1M for total revenue, while the sector average sits near $1.3B. That is roughly 99.9% below the sector mean. Large gaps often invite a closer look at Comera Life Sciences Holdings- Warrants (19/05/2027)'s growth, margins, and balance sheet.

A total revenue figure of $1M for CMRAW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $1.3B. Explore the charts below for those layers of context.

After noting CMRAW's total revenue ($1M), review year-over-year change from $550K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.